News

Acquisition of Texas facility to add 60,000 square feet of manufacturing space to company’s footprint

Provider will be CDMO’s primary material supplier in the lab, clinical, and production settings

Agreement focused on streamlining and automating manufacturing of cell and gene therapies

Partnership aims to lower prescription drug costs and increase price transparency

Global demand for advanced storage devices likely to fuel growth opportunities

Award given in recognition of CDMO’s commitment to promoting sustainable future

New facility expands presence in APAC region, providing additional availability to clients

Phoenix location will be company’s first to focus on high-density microarrays for diagnostic and life science research

Action enables the company to begin offering its unit-load device for shipments

Capacity is below 2021 levels

CDMO will be able to produce rAAV commercial grade product

Provides clientele with an augmented drug development solution

Provider’s regulatory affairs, pharmacovigilance services expected to help increase ABC’s portfolio

Semiannual update includes better revenue forecasting and state reporting

Collaboration aims to decrease environmental burden in the space

Lotte Biologics will assume facility ownership, as CDMO joins pharma space with the acquisition

The latest people news happenings over the past month

With the new additions, CDMO expands its analytical testing and development services

Confirms company’s commitment to ESG practices

Company offers less-than-24-hour delivery throughout Germany

Acquisition of Evolution Road expands company’s omnichannel know-how

Purchase strengthens Amgen’s therapeutics portfolio

Featuring manufacturing technology, the new facility supports medicines supply chain resilience

Will grow rental program that features environmentally friendly packaging

Big Pharma to collaborate with researchers from A*STAR, along with Singapore universities

Confirms cold chain company’s sustainability commitment

Will further boost CDMO’s injectable drug product platform

Biotech company’s AI/machine learning-enabled platform to design candidates for up to three drug discovery programs